Scleroderma News: New Guidelines Aim to Advance Plasma Exchange as Scleroderma Therapy

From Scleroderma News (SclerodermaNews.com), August 17, 2016:

The Scleroderma Education Project (SclerodermaInfo.org) recently released guidelines for patients and doctors wishing to know more about therapeutic plasma exchange (TPE) as a treatment option for limited scleroderma. The guidelines are designed to facilitate data collection to support the launch of a randomized clinical trial, and follow the same setup as a recently published case report describing the successful 22-year repeat treatment of a patient with limited scleroderma.

By following the guidelines, a physician who decides to use TPE with a scleroderma patient will allow researchers to pool and analyze data from that individual trial. This way, scientists can determine if a randomized clinical trial should be performed.

See the full news story for more information: Scleroderma News: Guidelines for Therapeutic Plasma Exchange Individual Trials for Scleroderma.

The guidelines document itself can be downloaded here:

US Format: Suggested Guidelines for Individual Trials of Therapeutic Plasma Exchange for Treating Systemic Scleroderma.

A4 FormatSuggested Guidelines for Individual Trials of Therapeutic Plasma Exchange for Treating Systemic Scleroderma.

For more information on these suggested Guidelines, contact the author at eharris@sclerodermainfo.org.

Share

Sorry, comments are closed for this post.